- Raised $2.1M Series B, Jun 2023
- Raised $700k Series A led by Solardis Health Ventures, Jun 2018
- Raised $1.5M Seed round
About
CardiaCare is a clinical stage Digital Therapeutic company that develops the world's first closed-loop wearable for non-invasive treatment of cardiac and other Central Nervous System related clinical symptoms. The device provides non-invasive nerve stimulation treatment with continuous monitoring and AI-based alerts capabilities, enabling complete remote patient management and personalized treatment. The technology employs a closed-loop approach involving both monitoring and therapy, utilizing non-invasive peripheral neuromodulation to mediate a cardiovascular antiarrhythmic response that reduces atrial fibrillation burden. CardiaCare has a functional prototype and successfully completed a FIM study. Multi-National RCT's are currently underway.
Funding history · 4 rounds · $4.3M total
Headcount over time
Q&A
- What is CardiaCare's primary focus?
- CardiaCare is a clinical stage Digital Therapeutic company that develops a wearable device for non-invasive treatment and monitoring of atrial fibrillation and other cardiac arrhythmias.
- When was CardiaCare founded?
- CardiaCare was founded in 2015.
- What is the total amount of funding CardiaCare has raised to date?
- CardiaCare has raised a total of $4,330,000 in funding.
- When did CardiaCare complete its most recent Seed extension round and who were the lead investors?
- In September 2023, CardiaCare completed a Seed extension round of $2,130,000. Solardis Health Ventures was a lead investor in this round.
- What is the status of CardiaCare's product development?
- CardiaCare has a functional prototype, has successfully completed a FIM study, and multi-national Randomized Controlled Trials (RCTs) are currently underway.
- How many employees does CardiaCare currently have?
- CardiaCare has 11-50 employees.
- What significant agreement did CardiaCare announce in December 2022?
- In December 2022, CardiaCare announced a licensing and distribution agreement to commercialize its digital neuromodulation wearable for non-invasive atrial fibrillation treatment.
- Who was appointed as the chair of CardiaCare's board in May 2023?
- In May 2023, CardiaCare named Ken Nelson as the chair of its board.
Team · 3
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | my-cardiacare.com |
|---|---|
| linkedin.com/company/28794323 |
Identifiers & details
| Founded | 2015 |
|---|---|
| Employees (exact) | 16 |
Radar intelligence
Web history (Wayback)
| Domain | my-cardiacare.com |
|---|
Certificate / subdomain footprint
| Subdomains | 1 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515187979 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2015-01-13 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 10 — shares_capital (3), people (2), other (1), violation (1), annual_report (3) |
| Registered address | רמון אילן 3 נס ציונה |
Recent registry events
| Date | Event |
|---|---|
| 2025-11-25 | שינוי בהרכב הון - מניות-פיצול מניה |
| 2026-01-21 | עדכון בעלי תפקידים |
| 2026-07-19 | שינוי בתקנון |
| 2025-11-16 | עדכון הפרה |
| 2025-11-16 | דו~ח שנתי-הוספת בעל תפקיד |
| 2025-11-16 | דו~ח שנתי-הקצאת מניות |
| 2025-11-16 | דו~ח שנתי-הוספת דירקטור |
| 2026-02-08 | הקצאת מניות |
| 2025-12-03 | העברת מניות |
| 2025-12-03 | עדכון דירקטורים-הסרת דירקטור |